Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Oral ulcers are common in SLE patients and often link to other symptoms.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Substance abuse can cause various skin problems, including marks from injections, sores, premature aging, and increased cancer risk.

Hair changes can indicate systemic diseases or medication effects.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

Levofloxacin may cause skin discoloration and hair loss as side effects.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

New insights in skin conditions show a complex link between certain moles and melanoma, improved hair loss treatments, and the need to identify different types of lupus.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Many survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo suffer long-term eye and skin problems.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Red and infrared light therapy improves hair growth in balding patients.

A 73-year-old man's grey-white hair turned dark brown after eczema treatment.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.